期刊文献+

不同剂量阿昔洛韦治疗带状疱疹疗效分析 被引量:3

Analysis of the effects of different dose of acyclovir in the treatment of Herpes zoste
下载PDF
导出
摘要 目的分析不同剂量阿昔洛韦治疗带状疱疹的疗效。方法收集我科2015年1月至2018年1月期间,住院并使用阿昔洛韦治疗带状疱疹的患者资料并进行回顾性分析。结果使用高剂量阿昔洛韦治疗组的无新发疹时间、开始结痂时间、疼痛缓解时间及平均住院日等指标均优于低剂量组。结论高剂量阿昔洛韦治疗带状疱疹疗效优于低剂量阿昔洛韦者。 Objective To analyze the effect of different doses of acvclovir in treatment of Herpes zoster.Methods The data of inpatients who dignosed with Herpes zoster and treated by acyclovir during January 2015 to January 2018 were retrospectively analyzed.Results The group using high-dose acyclovir are better than the low-dose group in the target of stopping new rashes,starting scabs,allaying pain and shorting average length of stay.Conclusion The effect on the treatment of Herpes zoster with high-dose acyclovir was better than that of low-dose acyclovir.
作者 王敏华 黄玲 黄静 倪昌雯 杨汝斌 陈超超 WANG Min-hua;HUANG Ling;HUANG Jing;NI Chang-wen;YANG Ru-bin;CHEN Chao-chao(Department of Dermatolog,the First Affiliated Hospital of Dali University,Dali,Yunnan 671000)
出处 《皮肤病与性病》 2020年第5期636-638,共3页 Dermatology and Venereology
基金 云南省皮肤免疫性疾病临床医学分中心建设项目。
关键词 带状疱疹 阿昔洛韦 疗效 Acyclovir Herpes zoster Curative effect
  • 相关文献

参考文献1

二级参考文献17

  • 1de Miranda P,Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration[J].Journal of Antimicrobial Chemotherapy,1983,(Suppl B):29-37.
  • 2Patel R. Valaciclovir:development,clinical utility and potential[J].Expert Opinion on Investigational Drugs,1997,(02):173-189.
  • 3Nikkels AF,Piérard GE. Oral antivirals revisited in the treatment of herpes zoster:what do they accomplish[J].American Journal of Clinical Dermatology,2002,(09):591-598.
  • 4Weller S,Blum MR,Doucette M. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single-and multiple-dose administration to normal volunteers[J].Clinical Pharmacology & Therapeutics,1993,(06):595-605.
  • 5Soul-Lawton J,Seaber E,On N. Absolute bioavailability and metabolic disposition of valaciclovir,the L-valyl ester of acyclovir,following oral administration to humans[J].Antimicrobial Agents and Chemotherapy,1995,(12):2759-2764.
  • 6van den Broek PJ,van der Meer JW,Mulder JD. Limited value of acyclovir in the treatment of uncomplicated herpes zoster:a placebo-controlled study[J].Infection,1984,(05):338-341.
  • 7Beutner KR,Friedman DJ,Forszpaniak C. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults[J].Antimicrobial Agents and Chemotherapy,1995,(07):1546-1553.
  • 8Gross G,Sch(o)fer H,Wassilew S. Herpes zoster guideline of the German Dermatology Society (DDG)[J].Journal of Clinical Virology,2003,(03):277-289.
  • 9Tyring SK,Douglas JM Jr,Corey L. A randomized,placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections.The Valaciclovir International Study Group[J].Archives of Dermatology,1998,(02):185-191.
  • 10Ormrod D,Goa K. Valaciclovir:a review of its use in the management of herpes zoster[J].Drugs,2000,(06):1317-1340.

共引文献25

同被引文献28

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部